Proxim Diagnostics Corp., an innovative company developing a handheld, point-of-care immunodiagnostic platform, announced ...

Lantern has successfully confirmed PTGR1 as a key biomarker that it intends to use to optimize patient selection based on potential tumor sensitivity to the drug candidate LP-184. LP-184 is a ...

"We would be happy to look at any suggestions to improve the development agreement and to move the project forward under ...

SAN DIEGO--(BUSINESS WIRE)-- Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced the ...

- Milestone earned upon reaching first enrollment target in a Phase 1/2 study of ARO-DM1 for the treatment of type 1 myotonic dystrophy PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, ...

The Energy Department says a small nuclear reactor under development at a national lab has reached a crucial milestone that ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ: SRPT). The ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...

2 January 2025 - While we’ve just counted down to a new year, another clock continues to tick: for the 2030 Agenda and its Sustainable Development Goals. In 2025 - the 80th anniversary of the United ...

First Enterprise Hub Delivered: Intellistake Technologies Corp. (CSE: ISTK) (OTCQB: ISTKF) (FSE:E41) has delivered the first iteration of the IntelliScope Enterprise AI Agent Hub to Powerbank ...

Limassol Greens marked its official inauguration on June 3, 2026, celebrating a major milestone in the evolution of one of Cyprus’ most significant integrated golf resort and residential developments.

The Hays County commissioners rejected Hays Commons development agreement after hours of public opposition.